Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Josh Michelson

Partner, Health & Life Sciences, Oliver Wyman

In the next decade, incumbents and innovators vying for a different relationship with consumers will shape healthcare’s front end.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

Hospital systems will be in a precarious position if they all aim for the same North Star. What might their evolution look like in coming years?

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

The pockets of innovation all around us provide early glimpses of a thriving future market.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

A breakdown of health systems' most common (and most time consuming) strategic agendas, based on our conversations with over 30 hospital systems.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

Disruption in healthcare will be driven by the power of its trapped – and highly exploitable – value.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Managing Partner, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

Why old-school payer-provider partnerships don’t cut it in today’s marketplace and a new kind of partnership is gaining hold.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

A comprehensive view of the ACO market, including a detailed look at “winners”, regional differences, and success rates by type.

Partner and Chief Medical Officer, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Associate, Oliver Wyman

Oliver Wyman analysis details the performance of ACOs by type (physician-led, hospital-led, commercial) and offers insight into what it will take for each to be successful.

Partner and Chief Medical Officer, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Despite changing political winds, value-based initiatives are as relevant as ever. Read new analysis of the ACO market and insight into next, best moves.

Partner, Health & Life Sciences, Oliver Wyman

Why old-school payer-provider partnerships don’t cut it in today’s marketplace and a new kind of partnership is gaining hold.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe